Workflow
融资融券
icon
Search documents
华电科工1月15日获融资买入1755.02万元,融资余额1.97亿元
Xin Lang Cai Jing· 2026-01-16 01:36
Group 1 - The core viewpoint of the news is that Huadian Technology Co., Ltd. experienced a decline in stock price and trading volume, with significant changes in financing and stockholder dynamics [1][2][3] Group 2 - On January 15, Huadian Technology's stock fell by 2.02%, with a trading volume of 216 million yuan. The financing data showed a net financing outflow of 8.63 million yuan for the day [1] - As of January 15, the total financing and securities lending balance for Huadian Technology was 197 million yuan, which is 1.94% of its market capitalization, indicating a low financing balance compared to the past year [1] - The company reported a revenue of 6.534 billion yuan for the period from January to September 2025, representing a year-on-year growth of 32.64%, and a net profit attributable to shareholders of 120 million yuan, up 11.58% year-on-year [2] Group 3 - Huadian Technology has distributed a total of 610 million yuan in dividends since its A-share listing, with 187 million yuan distributed over the past three years [3] - As of September 30, 2025, the number of shareholders increased to 39,300, while the average circulating shares per person decreased by 2.94% to 29,567 shares [2][3] - Notable changes in institutional holdings include a decrease in shares held by Hong Kong Central Clearing Limited and new entries from two funds, indicating shifts in investor sentiment [3]
陕西煤业1月15日获融资买入6052.61万元,融资余额7.68亿元
Xin Lang Cai Jing· 2026-01-16 01:33
Group 1 - The core viewpoint of the news is that Shaanxi Coal Industry has experienced a decline in stock performance and financial metrics, with a notable decrease in revenue and net profit year-on-year [2][3] - On January 15, Shaanxi Coal Industry's stock fell by 0.71%, with a trading volume of 624 million yuan, and a net financing purchase of 20.82 million yuan [1] - As of January 15, the total balance of margin trading for Shaanxi Coal Industry was 778 million yuan, indicating a low level compared to the past year [1] Group 2 - For the period from January to September 2025, Shaanxi Coal Industry reported an operating income of 118.08 billion yuan, a year-on-year decrease of 5.86%, and a net profit attributable to shareholders of 12.71 billion yuan, down 20.26% year-on-year [2] - The company has distributed a total of 81.64 billion yuan in dividends since its A-share listing, with 47.33 billion yuan distributed in the last three years [3] - As of September 30, 2025, the number of shareholders of Shaanxi Coal Industry increased to 105,000, while the average circulating shares per person decreased by 2.02% to 92,312 shares [2]
天赐材料1月15日获融资买入4.47亿元,融资余额27.61亿元
Xin Lang Cai Jing· 2026-01-16 01:33
Core Viewpoint - Tianqi Materials has shown significant trading activity with a notable increase in financing and shareholder numbers, indicating strong market interest and growth potential in the fine chemical new materials sector. Financing and Trading Activity - On January 15, Tianqi Materials' stock rose by 2.46% with a trading volume of 4.12 billion yuan, while the financing buy-in amounted to 447 million yuan and financing repayment was 465 million yuan, resulting in a net financing outflow of 18.30 million yuan [1] - As of January 15, the total financing and securities lending balance for Tianqi Materials was 2.768 billion yuan, with the financing balance at 2.761 billion yuan, representing 3.08% of the circulating market value, which is above the 90th percentile for the past year [1] - The securities lending activity on January 15 included a repayment of 9,200 shares and a sale of 2,300 shares, with a total sale value of 101,500 yuan, while the remaining securities lending balance was 15,710 shares, exceeding the 70th percentile for the past year [1] Company Performance - As of September 30, the number of shareholders for Tianqi Materials reached 305,800, an increase of 67.71%, while the average circulating shares per person decreased by 40.37% to 4,528 shares [2] - For the period from January to September 2025, Tianqi Materials reported a revenue of 10.843 billion yuan, reflecting a year-on-year growth of 22.34%, and a net profit attributable to shareholders of 421 million yuan, up 24.33% year-on-year [2] Dividend and Shareholder Structure - Since its A-share listing, Tianqi Materials has distributed a total of 2.857 billion yuan in dividends, with 2.023 billion yuan distributed over the past three years [3] - As of September 30, 2025, the top ten circulating shareholders included Hong Kong Central Clearing Limited as the second-largest shareholder with 53.6773 million shares, a decrease of 2.6555 million shares from the previous period [3] - Other notable shareholders include Quan Guo Xu Yuan Mixed A, which increased its holdings by 8.5152 million shares, and new entrant Penghua CSI Subdivision Chemical Industry Theme ETF, holding 20.1206 million shares [3]
中信重工1月15日获融资买入6215.13万元,融资余额9.22亿元
Xin Lang Cai Jing· 2026-01-16 01:33
Group 1 - On January 15, CITIC Heavy Industries experienced a decline of 2.38% with a trading volume of 518 million yuan, and the net financing purchase amounted to 19.91 million yuan [1] - As of January 15, the total margin balance for CITIC Heavy Industries was 934 million yuan, with a financing balance of 922 million yuan, representing 2.91% of the circulating market value, which is above the 90th percentile of the past year [1] - The company’s main business revenue composition includes mining and heavy equipment (56.17%), new energy equipment (20.39%), special materials (18.23%), and robotics and intelligent equipment (5.21%) [1] Group 2 - As of September 30, the number of shareholders for CITIC Heavy Industries was 109,100, a decrease of 19.13% from the previous period, while the average circulating shares per person increased by 23.66% to 41,711 shares [2] - For the period from January to September 2025, CITIC Heavy Industries reported a revenue of 5.906 billion yuan, a year-on-year increase of 0.49%, and a net profit attributable to shareholders of 285 million yuan, up 0.27% year-on-year [2] Group 3 - Since its A-share listing, CITIC Heavy Industries has distributed a total of 1.099 billion yuan in dividends, with 304 million yuan distributed over the past three years [3] - As of September 30, 2025, the fourth largest circulating shareholder is E Fund National Robot Industry ETF, holding 58.6088 million shares, while the fifth largest is Huaxia CSI Robot ETF, which increased its holdings by 9.4259 million shares to 50.4355 million shares [3]
中材节能1月15日获融资买入527.51万元,融资余额1.41亿元
Xin Lang Cai Jing· 2026-01-16 01:33
1月15日,中材节能涨0.58%,成交额4663.26万元。两融数据显示,当日中材节能获融资买入额527.51 万元,融资偿还464.45万元,融资净买入63.05万元。截至1月15日,中材节能融资融券余额合计1.41亿 元。 融资方面,中材节能当日融资买入527.51万元。当前融资余额1.41亿元,占流通市值的3.34%,融资余 额低于近一年50%分位水平,处于较低位。 分红方面,中材节能A股上市后累计派现4.45亿元。近三年,累计派现1.09亿元。 机构持仓方面,截止2025年9月30日,中材节能十大流通股东中,金元顺安元启灵活配置混合 (004685)位居第五大流通股东,持股203.11万股,相比上期减少16.89万股。 责任编辑:小浪快报 融券方面,中材节能1月15日融券偿还0.00股,融券卖出1000.00股,按当日收盘价计算,卖出金额 6920.00元;融券余量1100.00股,融券余额7612.00元,超过近一年90%分位水平,处于高位。 资料显示,中材节能股份有限公司位于天津市北辰区高峰路与天宁道交口中材节能大厦,成立日期1998 年6月1日,上市日期2014年7月31日,公司主营业务涉及水泥 ...
禾丰股份1月15日获融资买入941.32万元,融资余额1.73亿元
Xin Lang Cai Jing· 2026-01-16 01:33
Group 1 - The core viewpoint of the news is that He Feng Co., Ltd. has shown significant trading activity, with a notable increase in financing and a decrease in short selling, indicating investor interest and market dynamics [1][2]. - On January 15, He Feng Co., Ltd. experienced a stock price increase of 1.24%, with a trading volume of 35.07 million yuan. The financing buy-in amount was 9.41 million yuan, while the net financing buy-in was 4.45 million yuan, indicating strong demand for the stock [1]. - As of January 15, the total financing and securities lending balance for He Feng Co., Ltd. was 173 million yuan, which represents 2.60% of its market capitalization, indicating a high level of financing activity compared to the past year [1]. Group 2 - As of September 30, the number of shareholders for He Feng Co., Ltd. increased to 22,500, a rise of 4.18%, while the average circulating shares per person decreased by 4.01% to 40,474 shares [2]. - For the period from January to September 2025, He Feng Co., Ltd. reported a revenue of 28.07 billion yuan, reflecting a year-on-year growth of 16.92%. However, the net profit attributable to shareholders decreased by 55.34% to 129 million yuan [2]. - Since its A-share listing, He Feng Co., Ltd. has distributed a total of 1.007 billion yuan in dividends, with 158 million yuan distributed over the past three years [3].
斯莱克1月15日获融资买入4850.19万元,融资余额7.43亿元
Xin Lang Cai Jing· 2026-01-16 01:33
Core Viewpoint - Sleek experienced a decline of 3.52% in stock price on January 15, with a trading volume of 347 million yuan, indicating potential market volatility and investor sentiment shifts [1] Financing and Margin Trading - On January 15, Sleek had a financing buy-in amount of 48.50 million yuan and a financing repayment of 32.32 million yuan, resulting in a net financing buy of 16.18 million yuan [1] - As of January 15, the total margin trading balance for Sleek was 743 million yuan, accounting for 7.59% of its market capitalization, which is above the 90th percentile of the past year, indicating a high level of leverage [1] - In terms of securities lending, Sleek had no shares repaid or sold on January 15, with a remaining short position of 15,600 shares and a margin balance of 235,400 yuan, which is below the 10th percentile of the past year, indicating low short interest [1] Company Overview - Suzhou Sleek Precision Equipment Co., Ltd. was established on January 6, 2004, and went public on January 29, 2014. The company specializes in the research, design, production, and assembly of equipment for metal packaging products, including high-speed easy-open lids and cans [2] - The revenue composition of Sleek includes: battery shell business (67.48%), high-speed production equipment for easy-open lids and system upgrades (11.43%), other specialized equipment and spare parts (8.87%), high-speed production equipment for cans and system upgrades (7.59%), photovoltaic power generation and others (3.04%), and intelligent detection equipment (1.58%) [2] - For the period from January to September 2025, Sleek achieved a revenue of 1.63 billion yuan, representing a year-on-year growth of 50.85%, and a net profit attributable to shareholders of 14.63 million yuan, reflecting a significant increase of 195.39% [2] Dividend Information - Since its A-share listing, Sleek has distributed a total of 869 million yuan in dividends, with 248 million yuan distributed over the past three years [3] Institutional Holdings - As of September 30, 2025, the second-largest circulating shareholder of Sleek is Yongying Advanced Manufacturing Smart Selection Mixed Fund A, holding 30.87 million shares, an increase of 1.87 million shares from the previous period [4] - The fourth-largest circulating shareholder is Penghua Carbon Neutral Theme Mixed Fund A, holding 19.87 million shares, a decrease of 1.14 million shares from the previous period [4] - Hong Kong Central Clearing Limited is the seventh-largest circulating shareholder, holding 6.64 million shares, an increase of 226,410 shares from the previous period [4]
新宝股份1月15日获融资买入706.79万元,融资余额2.24亿元
Xin Lang Cai Jing· 2026-01-16 01:33
Group 1 - The core viewpoint of the news is that Xinbao Co., Ltd. has shown mixed financial performance, with a slight decrease in revenue but an increase in net profit, indicating potential resilience in profitability despite revenue challenges [2]. - As of January 15, Xinbao's stock price increased by 0.35%, with a trading volume of 81.41 million yuan. The financing buy-in amount was 7.07 million yuan, while the financing repayment was 11.68 million yuan, resulting in a net financing outflow of 4.61 million yuan [1]. - The total financing and securities balance for Xinbao reached 225 million yuan, with the financing balance accounting for 1.90% of the circulating market value, indicating a relatively high level compared to the past year [1]. Group 2 - As of January 9, the number of shareholders for Xinbao increased to 28,300, a rise of 2.42%, while the average circulating shares per person decreased by 2.36% to 28,511 shares [2]. - For the period from January to September 2025, Xinbao reported an operating income of 12.28 billion yuan, a year-on-year decrease of 3.20%, while the net profit attributable to shareholders increased by 7.13% to 841 million yuan [2]. - Xinbao has distributed a total of 3.195 billion yuan in dividends since its A-share listing, with 1.14 billion yuan distributed over the past three years [2]. Group 3 - As of September 30, 2025, the top ten circulating shareholders of Xinbao included Hong Kong Central Clearing Limited as the third-largest shareholder, holding 29.28 million shares, a decrease of 3.06 million shares from the previous period [3]. - New shareholders included China Europe Pension Mixed A, holding 7.41 million shares, while other funds like Fuguo Stable Enhanced Bond A/B and Fuguo Double Bond Enhanced Bond A increased their holdings [3]. - The South China Securities 1000 ETF reduced its holdings by 23,800 shares, while other shareholders like Dongfanghong New Power Mixed A maintained their share count [3].
我武生物1月15日获融资买入1490.06万元,融资余额4.30亿元
Xin Lang Cai Jing· 2026-01-16 01:33
Core Viewpoint - Iwubio experienced a decline of 0.58% in stock price on January 15, with a trading volume of 173 million yuan, indicating a potential shift in investor sentiment and market dynamics [1] Financing Summary - On January 15, Iwubio had a financing buy amount of 14.90 million yuan and a financing repayment of 36.21 million yuan, resulting in a net financing outflow of 21.31 million yuan [1] - The total financing and securities balance for Iwubio as of January 15 is 430 million yuan, which accounts for 2.66% of its market capitalization, indicating a relatively high financing balance compared to the past year [1] - The company had a securities lending repayment of 1,500 shares on January 15, with no shares sold, and a remaining securities lending balance of 11,300 shares valued at 349,100 yuan, which is low compared to the past year [1] Business Performance - As of September 30, Iwubio reported a total of 32,400 shareholders, a decrease of 6.22% from the previous period, while the average circulating shares per person increased by 6.63% to 14,927 shares [2] - For the period from January to September 2025, Iwubio achieved an operating income of 853 million yuan, representing a year-on-year growth of 16.86%, and a net profit attributable to shareholders of 345 million yuan, reflecting a growth of 26.67% [2] Dividend and Shareholding Information - Since its A-share listing, Iwubio has distributed a total of 965 million yuan in dividends, with 369 million yuan distributed over the past three years [3] - As of September 30, 2025, among the top ten circulating shareholders, Hong Kong Central Clearing Limited is the fourth largest with 5.56 million shares, an increase of 1.45 million shares from the previous period [3] - New institutional shareholders include Jiashi Mutual Fund and Penghua Medical Technology Fund, holding 4.71 million shares and 4.30 million shares respectively, while the China Merchants National Bio-Medical Index Fund reduced its holdings by 783,300 shares [3]
泰格医药1月15日获融资买入3999.19万元,融资余额6.73亿元
Xin Lang Cai Jing· 2026-01-16 01:33
Core Viewpoint - On January 15, Tiger Med experienced a slight decline of 0.38% with a trading volume of 700 million yuan, indicating a low level of financing and margin trading activity [1][2]. Financing Summary - On January 15, Tiger Med had a financing buy amount of 39.99 million yuan and a financing repayment of 40.44 million yuan, resulting in a net financing outflow of 446,300 yuan. The total financing and margin trading balance reached 675 million yuan [1]. - The current financing balance is 673 million yuan, which accounts for 1.45% of the circulating market value, indicating a low level compared to the past year [1]. Margin Trading Summary - On January 15, Tiger Med repaid 100 shares in margin trading and sold 1,300 shares, with a selling amount of 81,600 yuan based on the closing price. The margin trading balance is 1.59 million yuan, which is also low compared to the past year [1]. Company Overview - Tiger Med, established on December 15, 2004, and listed on August 17, 2012, is located in Hangzhou, Zhejiang Province. The company specializes in providing professional clinical research services for domestic and international pharmaceutical and health-related products [2]. - The main business revenue composition includes clinical trial-related services and laboratory services (52.60%), clinical trial technical services (45.21%), and other services (2.19%) [2]. Financial Performance - For the period from January to September 2025, Tiger Med reported a revenue of 5.026 billion yuan, a year-on-year decrease of 0.82%. However, the net profit attributable to the parent company was 1.020 billion yuan, reflecting a year-on-year increase of 25.45% [2]. Dividend Information - Since its A-share listing, Tiger Med has distributed a total of 2.458 billion yuan in dividends, with 1.154 billion yuan distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, Tiger Med had 48,400 shareholders, a decrease of 6.01% from the previous period. The average circulating shares per person remained at 0 shares [2][3]. - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 48.3625 million shares, an increase of 25.0969 million shares from the previous period [3].